Mobile

A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Activity of GS 9450 in Adults with Non-Alcoholic Steatohepat...

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-002361-31

A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Activity of GS 9450 in Adults with Non-Alcoholic Steatohepatitis (NASH)

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

• To investigate the safety and tolerability of multiple oral doses of GS 9450 in subjects with NASH

Critère d'inclusion

  • Non-alcoholic Steatohepatitis (NASH)

Liens